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ABSTRACT
Objectives: The aim is to evaluate the anticancer potential of Annona squamosa (AS) against 7, 12-dimethylbenz(a)anthracene (DMBA)-induced 
mammary carcinoma in rats.
Methods: The tumor was induced in Sprague-Dawley rats by gastric intubation of 25 mg DMBA in 1 ml olive oil. After 3 months of induction period, the 
methanolic extract of AS at different doses of 100, 150, 200, 250, and 300 mg/kg body weight were administered orally a dose per day to mammary 
carcinoma-bearing rats for 45 days. The serum and tissue levels of glycoprotein components as well as the activities of marker enzymes and lysosomal 
enzymes were measured in DMBA-induced mammary carcinoma-bearing rats.
Results: Administration of AS resulted in decrease in the levels of marker and lysosomal enzymes and also alterations in the body weight and tumor 
volume were also restored to near normalcy in a dose-dependent manner. The results of the present study indicate that AS has anticancer effect and 
it exhibits its potential effect at the dosage of 200 mg/kg body weight in mammary carcinoma-bearing rats.
Conclusions: Based on the results obtained, it can be concluded that the methanol extract of AS possesses anticancer properties. Further study is 
needed to isolate the active principle of this extract responsible for anticancer activity to develop the future pharmaceuticals.
Keywords: Annona squamosa, 7, 12-dimethylbenz(a)anthracene, Glycoproteins, Lysosomal enzymes, Marker enzymes, Mammary carcinoma.
INTRODUCTION
Cancer is based on genetic and epigenetic alterations that affect the 
regulation and function of genes. These pathologic changes are selected 
during progression to yield cells that multiply aggressively beyond the 
limits normally set by their intrinsic proliferative capacity, neighboring 
cells, limited mitogens, and blood supply [1]. Breast cancer is the 
most common malignant disease affecting women worldwide [2]. It 
accounts for about one-fourth of all cancers in Indian women with high 
morbidity and high mortality rate [3]. It is estimated that by 2030, the 
number of new cases of breast cancer in India will reach just fewer 
than 200,000/year. The Indian National Cancer Registry Programme 
reported that the burden of breast cancer patients will be increased to 
123,634 by the year 2020 [4].
In addition to the therapeutic strategies, development of target-specific 
drugs to treat metastatic breast cancer [5]. The earliest adjuvant 
chemotherapy, with single-agent alkylating and antimetabolic drugs, 
has now been replaced by combination therapy, as it was demonstrated 
that simultaneous combination of two or more agents provided better 
results [6].
Annona squamosa Linn. (AS), Annonaceae, is popularly known as 
custard apple. It has been cultivated all over India and traditionally 
used for the treatment of dysentery, cardiac problems, fainting, worm 
infections, constipation, hemorrhage, dysuria, fever, thirst, malignant 
tumors, ulcer, and also an abortifacient [7,8]. The white creamy fruit 
pulp is soft, edible, so it is employed in preparing cool drinks, and 
flavor ice puddings. Unripe fruits are dried and powdered to treat ulcer, 
diarrhea, dysentery, and atonic dyspepsia. It is mixed with gram flour 
and it has been used to destroy vermin. Ripe fruit made into paste with 
betel leaves hasten suppuration in tumors [9]. Recently, AS peel extract 
is reported to have acaricidal, insecticidal, and larvicidal and also it is 
used for the biosynthesis of palladium and silver nanoparticles [10]. 
In our pervious study, we have analyzed the phytoconstituents of 
methanolic and aqueous extract of AS qualitatively and the results 
showed number of phenolic and flavonoidal compounds. Among these 
two extracts, methanolic extract of AS showed better radical scavenging 
activity than the aqueous extract [11].
The present study was designed to study the therapeutic efficacy of 
methanolic extract of AS on 7, 12-dimethylbenz(a)anthracene (DMBA)-
induced mammary carcinoma-bearing rats. The status of glycoprotein 
components, lysosomal enzymes, and tumor marker enzymes in the 




Fresh AS fruits were collected from a local market in Chennai, Tamil 
Nadu, India. The fruits were identified with reference to the Flora of the 
Presidency of Madras by Gamble [12].
Extraction procedure
Methanolic extract of AS has exhibited good radical scavenging activity 
and has revealed the presence of phenols and flavonoids than the 
aqueous extract [11]. Further research work was carried using the 
methanol extracts of AS. About 50 g of AS fruit pulp was weighed 
accurately and soaked in 50 ml of methanol and kept in a dark place 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i9.17836
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for 3 days in a shaker. Carbon dioxide was released frequently. After 
3 days, sample was filtered and the filtrate was kept in a water bath 
at about 40°C to concentrate them. The concentrated filtrate obtained 
was used for further studies to determine the effective dose at different 
concentrations.
Chemicals and reagents
DMBA, nicotinamide adenine dinucleotide+, adenosine 
5’-monophosphate, and N-acetylmuramic acid, and other fine chemicals 
were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other 
chemicals and solvents used were of analytical grade and highest purity.
Animals
Adult female rats of Sprague-Dawley strain weighing 195-205 g 
were provided by the Central Animal House facility, University of 
Madras, Taramani Campus, Chennai - 600 113, Tamil Nadu, India. The 
animals were maintained under the standard conditions of humidity, 
temperature (25±2°C), and light (12 hrs light/dark). They were fed 
with standard rat pellet diet and water ad libitum. This study has got 
approval from the Institutional Animal Ethical Committee, regulated 
by the Committee for the Purpose of Control and Supervision of 
Experiments on Animals, Ministry of Environment and Forests (Animal 
Welfare Division), Government of India (No. 01/030/2011).
Experimental design
The rats were divided into seven groups with six animals in each group 
and were given the dose regimen as given below.
•	 Group	I:	Control	animals.
•	 Group	II:	Breast	cancer	was	induced	in	overnight-fasted	animals	by	
a single dose of DMBA in olive oil (25 mg/kg body weight) by gastric 
intubation.
•	 Group	III:	Breast	cancer-induced	animals	(as	in	Group	II)	were	treated	
with the drug, methanol extract of AS (100 mg/kg body weight/day) 
in olive oil orally by gastric intubation for 45 days.
•	 Group	IV:	Breast	cancer-induced	animals	were	treated	with	the	drug,	
methanol extract of AS (150 mg/kg body weight/day) in olive oil 
orally by gastric intubation for 45 days.
•	 Group	V:	Breast	cancer-induced	animals	were	treated	with	the	drug,	
methanol extract of AS (200 mg/kg body weight/day) in olive oil 
orally by gastric intubation for 45 days.
•	 Group	VI:	Breast	cancer-induced	animals	were	treated	with	the	drug,	
methanol extract of AS (250 mg/kg body weight/day) in olive oil 
orally by gastric intubation for 45 days.
•	 Group	VII:	Breast	 cancer-induced	animals	 (as	 in	Group	 II)	were	
treated with the drug, methanol extract of AS (300 mg/kg body 
weight/day) in olive oil orally by gastric intubation for 45 days.
Group II animals induced with breast cancer were latter treated with the 
drugs of methanol extracts of AS. The body weight, organs weight, and 
mean	tumor	volume	were	calculated	according	to	the	formula	v=4/3πr12r2 
(radius r1<r2; r=tumor diameter in mm/2) [13]. Liver and mammary gland 
were washed well with ice-cold saline and homogenized in Tris-HCl buffer 
(0.1 M, pH 7.4). Blood was also collected for further analysis.
Enzyme assays
The levels of glycoprotein components, namely, hexose, hexosamine, and 
sialic acid in plasma, liver, and mammary gland were estimated by the 
method of Niebes, Wagner, and Warren, respectively [14-16]. The values 
are expressed as mg/dl for plasma and mg/g of defatted tissue. Protein 
was estimated by the method of Lowry et al. [17]. Acid phosphatase 
and Cathepsin D (CAT-D) enzyme activities were measured by the 
method of King and Sapolsky [18,19] and their values are expressed 
as µmoles of phenol liberated per min/mg protein, µmoles of tyrosine 
liberated	min/mg	protein,	respectively.	αD-glucuronidase	was	assayed	
by the method of Kawai and Anno [20] and the activity was expressed 
as µmoles of p-nitrophenol formed per min/mg protein.
The	assay	of	γ-glutamyl	transferase	(γ-GT)	was	carried	out	according	to	
the Rosalki and Rau [21]. The activity was expressed as IU/L for plasma 
and µmoles of p-nitroaniline liberated per minute/mg of protein for 
tissue.
Lactate dehydrogenase (LDH) was assayed by the method of King [22] 
and its activity is expressed as IU/L for plasma and µmoles of 
pyruvate liberated per minute/mg of protein for tissue. The activity of 
5’-nucleotidase (ND) was determined by the method of Luly et al. [23] 
and expressed as µmoles of phosphorus liberated per minute/mg of 
protein. The amount of phosphorus liberated was estimated by Fiske 
and Subbarow method [24].
Statistical analysis
Values	are	given	as	the	mean±standard	deviation	of	six	rats.	The	results	
were statistically evaluated using Student’s t-test using Statistical 
Package for the Social Sciences 16 software and one-way analysis of 
variance. The differences between the groups were considered as 
significant at *p<0.05.
RESULTS
The body weight and organ weights such of liver and kidneys were 
significantly decreased (p<0.05), whereas their volume was found to be 
enormously elevated (p<0.05) in mammary carcinoma-bearing rats. On 
treatment with AS at different concentrations, the body weight, organ 
weights, and tumor volumes were significantly recoupled back to near 
normal conditions in a dose-dependent manner. AS at a concentration of 
200 mg/kg body weight was found to be the effective dosage (Table 1).
The levels of glycoproteins in plasma, liver, and mammary tissue of 
control and experimental animals were studied. Elevated levels of 
protein-bound carbohydrate components such as hexose, hexosamine, 
and sialic acid in plasma, liver, and mammary tissue were observed 
in cancer-induced rats when compared to the control rats. After 
treatment with AS, the glycoprotein levels were significantly decreased 
in drug-treated animals in a dose-dependent manner when compared 
to mammary carcinoma-bearing rats. The drug treatment at the 
concentration of 200 and 250 mg/kg showed a highly significant effect 
(p<0.05) when compared with cancer-induced animals (Fig. 1 and 
Table 2).
Lysosomal enzymes, namely, acid phosphatase, CAT-D were studied in 
plasma, liver, and mammary tissue of control and experimental rats. 
The activities of lysosomal enzymes were found to be significantly 
increased (p<0.05) in carcinoma-induced animals than in control 
animals. On drug treatment, the levels were significantly decreased in a 
dose-dependent manner showing a favorable change in groups treated 
with 200 mg/kg of the drug AS (Figs. 2-4).
The	levels	of	marker	enzymes	such	as	γ-GT,	LDH,	and	ND	in	plasma	and	
liver of control and experimental animals are depicted in Table 3. The 
marker enzymes were found to be significantly increased in mammary 
carcinoma-bearing rats when compared to control rats. There was a 
significant decrease in the levels of these enzymes in AS-treated groups 
with a higher significance in 200 mg/kg body weight treatment.
DISCUSSION
More than 13,000 plants have been studied during the past 5-year 
period for the development of new chemotherapeutic agents [25]. Use 
of herbal products has grown dramatically in the Western world. With 
the narrow therapeutic range associated with most anticancer drugs, 
there is an increasing need for understanding possible adverse drug 
interactions in medical oncology [24]. The present study was carried 
out to estimate the anticancer potential of the AS on DMBA-induced 
mammary carcinoma in rats. The results showed that administration 
of AS at the dosage of 200 mg/kg body weight exhibited enhanced 
anticancer effect.
It is well known that in cancer condition, excessive energy expenditure 
of the host, ultimately contribute to mechanisms that promote weight 
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loss [26]. The weight loss indicates poor diagnosis and tinier survival 
time for cancer patients [27]. On drug treatment, the body weight was 
increased. This indicates the curative property of the AS. Medicinal 
herbs have been shown to improve appetite, food intake, malnutrition, 
fatigue, and sensation of well-being which could elicit body weight 
gain	 [28].	 In	 AS-treated	 Groups	 III-VII,	 the	 tumor	 did	 not	 disappear	
totally, but a significant regression was found when compared to 
induced Group II showing the inhibitory action of the drug on tumor 
growth. Many studies in different cell lines, animal models, and human 
epidemiological trials have shown the potential of dietary polyphenols 
acting as potential anticarcinogenic agents [29]. Flavonoids are reported 
to have inhibitory action on various stages of tumor development in 
animal studies [30].
On drug administration, the body weight was significantly increased. 
It indicates the antineoplastic activity of the drug. This might be due 
to the presence of various polyphenols, flavonoids, and catechins in 
the methanolic extract of AS [31]. The inhibiting property may be due 
to the presence of flavonoids, as they have been reported to import 
antiproliferative active action on several cancer cell.
Carbohydrates are familiar as differentiation markers and as antigenic 
determinations. Modified carbohydrates and oligosaccharides have 
the ability to impede with carbohydrate–protein interactions and 
therefore, inhibit the cell – cell recognition and adhesion processes that 
play an important role in cancer growth and metastasize [32]. Tumor 
metastasis results in death since various treatment strategies have 
developed [33]. Alterations in the glycoprotein metabolism have been 
demoralized for the diagnosis of growth [34]. Sialic acid, glycopeptides 
present in the surface of malignant cell lines [35]. The combined 
evaluation of these carbohydrate residues of glycoproteins might help 
to establish potential beneficial effect in the diagnosis and treatment 
monitoring of mammary cancer patients [36].
Fig. 1: Effect of Annona squamosa (AS) on the levels of 
glycoprotein components in plasma of experimental rats. Values 
are expressed as mean±standard deviation; n=6. Group I - 
Control, Group II - Mammary carcinoma induced, Groups III, IV, 
V, VI, and VII - Mammary carcinoma induced and treated with 
AS at the dosage of 100, 150, 200, 250, and 300 mg/kg body 
weight/day, respectively. aWhen compared with Group I; bwhen 
compared with Group II; Statistical significance: *p<0.05
Fig. 2: The levels of acid phosphatase (ACP), β-glucuronidase 
(β-GLU), and cathepsin-D (CAT-D) activities in the plasma of 
experimental rats. Values are expressed as mean±standard 
deviation; n=6. Units: ACP - µmole of phenol liberated per 
min/mg protein; β-GLU - µmole of p-nitrophenol formed 
per min/mg protein; CAT-D - µmole of tyrosine liberated 
per min/mg protein. Group I - Control, Group II - Mammary 
carcinoma induced, Groups III, IV, V, VI, and VII - Mammary 
carcinoma induced and treated with Annona squamosa at the 
dosage of 100, 150, 200, 250, and 300 mg/kg body weight/day, 
respectively. aWhen compared with Group I; bwhen compared 
with Group II; Statistical significance: *p<0.05
Table 1: Effect of AS on body weight, organs weight, and tumor volume in the experimental rats
Parameters Group I Group II Group III Group IV Group V Group VI Group VII
Body weight (g)
Initial 183.5±10.6 185.43±9.54 181.85±5.43 183.28±7.34 184.75±6.7 185.89±7.32 184.34±9.45
Final 249.91±8.3 204.81±8.54a* 217.6±9.48b 224.8±11.2b* 251.28±10.4b* 254.56±8.56b* 253.87±19.21b*
Organ weight (g)
Liver 8.2±0.59 6.51±0.45a* 6.59±0.51b 7.21±0.54b 7.65±0.62b* 7.72±0.59b* 7.69±0.61b*
Kidneys 1.96±0.14 1.32±0.11a* 1.34±0.12b 1.52±0.14b 1.88±0.17b* 1.89±0.17b* 1.88±0.18b*
Tumor volume (mm3) - 5210±437a* 4865±386b 44478±312b* 4054±389b* 4010±356b* 4085±348b*
Values	are	expressed	as	mean±standard	deviation;	n=6.	Group	I	-	Control,	Group	II	-	Mammary	carcinoma	induced,	Groups	III,	IV,	V,	VI	and	VII	-	Mammary	carcinoma	
induced and treated with AS at the dosage of 100, 150, 200, 250, and 300 mg/kg body weight/day, respectively. aWhen compared with Group I; bwhen compared with 
Group II; Statistical significance: *p<0.05. AS: Annona squamosa, SD: Standard deviation
Table 2: Effect of AS on the levels of glycoprotein components in experimental rats
Parameters (mg/g of 
defatted tissue)
Group I Group II Group III Group IV Group V Group VI Group VII
Liver
Hexose 4.01±0.37 11.54±0.93a* 9.59±0.78b 6.44±0.61b* 4.89±0.44b* 4.76±0.41b* 4.79±0.39b*
Hexosamine 3.56±0.28 9.04±0.89a* 7.49±0.66b 4.23±0.37b* 4.19±0.38b* 4.23±0.37b* 4.15±0.36b*
Sialic acid 3.06±0.24 7.15±0.71a* 6.33±0.45b 4.78±0.41b* 3.52±0.33b* 3.61±0.35b* 3.51±0.32b*
Mammary tissue
Hexose 2.04±0.19 4.98±0.29a* 4.33±0.4b 3.98±0.32b* 2.56±0.19b* 2.43±0.23b* 2.46±0.23b*
Hexosamine 0.89±0.06 1.78±0.09a* 1.53±0.11b 1.33±0.12b* 1.06±0.09b* 1.02±0.08b* 1.08±0.11b*
Sialic acid 0.22±0.02 0.74±0.06a* 0.69±0.05b 0.51±0.04b* 0.29±0.02b* 0.29±0.02b* 0.28±0.03b*
Values	are	expressed	as	mean±SD;	n=6.	Group	I	-	Control,	Group	II	-	Mammary	carcinoma	induced,	Groups	III,	IV,	V,	VI	and	VII	-	Mammary	carcinoma	induced	and	treated	
with AS at the dosage of 100, 150, 200, 250, and 300 mg/kg body weight/day, respectively. aWhen compared with Group I, bwhen compared with Group II; Statistical 
significance: *p<0.05. AS: Annona squamosa, SD: Standard deviation 
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The glycoprotein components levels were reverted to near normal 
levels on the AS treatment condition, due to the cytostabilizing 
property of AS fruit. Isoflavones and flavonoids prominently decrease 
the activity of glycoproteins levels [37]. Flavonoids have been proved to 
possess inhibitory action against carcinogenesis [38]. Flavonoids acts 
as inducer of apoptosis and acts as a potent antiproliferative agent and 
this strategy suggest their potential use in cancer control [39]. Thus 
the flavonoids, alkaloids, and other bioactive components of the drug 
might have significantly altered the expression of glycosyltransferases 
and thereby modulated glycoprotein synthesis and protected the 
structural reliability of cell surface and membrane, indicating its potent 
anticancer property.
High levels of lysosomal enzymes released from tumor cells have local 
and systemic effects [35]. The activities of lysosomal enzymes are linked 
to evolution and regression of mammary cancer [34]. Lysosomes are a 
group of cytoplasmic organelles present in numerous animal tissues, 
characterized by their control of acid hydrolases. These cytoplasmic 
vesicles contain hydrolytic enzymes that are capable of digesting the 
macromolecules such as polysaccharides, nucleic acid, and lipids [40]. 
Malignant tumors contain high levels of lysosomal enzymes which 
may have local and systemic effects when released from the tumor. 
Increase of lysosomal enzymes in cancerous condition, it may be due 
to the abnormal fragility of the lysosomes, which depends on the 
damage of cell membrane due to the vast production of free radicals in 
the cancerous condition [41]. The lysosomal aspartic protease CAT-D 
is overexpressed and hypersecreted by epithelial breast cancer cells. 
This protease is an independent marker of poor prognosis in breast 
cancer being correlated with the incidence of clinical metastasis. CAT-D 
overexpression stimulates tumorigenicity and metastasis [42].
The decreased enzymes activities observed on AS treatment could be 
an evidence for its ability to significantly reduce the leakage of enzymes 
most likely through stabilizing the membrane architecture which could 
have been impacted by the flavonoids.
Fig. 3: The levels of acid phosphatase (ACP), β-glucuronidase 
(β-GLU), and cathepsin-D (CAT-D) activities in the liver of 
experimental rats. Values are expressed as mean±standard 
deviation; n=6. Units: ACP - µmole of phenol liberated per 
min/mg protein; β-GLU - µmole of p-nitrophenol formed 
per min/mg protein; CAT-D - µmole of tyrosine liberated 
per min/mg protein. Group I - Control, Group II - Mammary 
carcinoma induced, Groups III, IV, V, VI, and VII - Mammary 
carcinoma induced and treated with Annona squamosa at the 
dosage of 100, 150, 200, 250, and 300 mg/kg body weight/day, 
respectively. aWhen compared with Group I; bwhen compared 
with Group II; Statistical significance: *p<0.05
Fig. 4: The levels of acid phosphatase (ACP), β-glucuronidase 
(β-GLU), and cathepsin-D (CAT-D) activities in experimental 
rat. Values are expressed as mean±standard deviation; n=6. 
Units: ACP - µmole of phenol liberated per min/mg protein; 
β-GLU - µmole of p-nitrophenol formed per min/mg protein; 
CAT-D - µmole of tyrosine liberated per min/mg protein. Group I – 
Control, Group II - Mammary carcinoma induced, Groups III, 
IV, V, VI, and VII - Mammary carcinoma induced and treated 
with Annona squamosa at the dosage of 100, 150, 200, 250, and 
300 mg/kg body weight/day, respectively. aWhen compared with 
Group I; bwhen compared with Group II; Statistical significance: 
*p<0.05
Table 3: Effect of AS on marker enzymes in plasma, liver, and mammary tissues in experimental rats
Parameters Control Induced Induced+treated with AS at different dose
Group I Group II Group III Group IV Group V Group VI Group VII
Plasma
γ-GT	(IU/L) 1.56±0.13 2.89±0.26a* 2.68±0.24b 2.36±0.23b 1.82±0.16b* 1.85±0.18b* 1.84±0.17b*
LDH (IU/L) 0.42±0.04 1.66±0.11a* 1.53±0.13b 1.11±0.09b 0.78±0.05b* 0.75±0.06b* 0.78±0.06b*
5’-ND	(μmol	of	Pi	liberated/min/mg	
protein) 
3.86±0.28 5.44±0.41a* 4.89±0.43b 4.42±0.38b 3.94±0.33b* 4.10±0.37b* 3.91±0.35b*
Liver
γ-GT	(µmoles	of	p-nitroaniline	
liberated per minute/mg of protein)
4.11±0.39 7.43±0.64a* 6.78±0.54b 5.44±0.43b 4.56±0.34b* 4.62±0.44b* 4.59±0.41b*
LDH (µmoles of pyruvate liberated 
per minute/mg of protein)
2.65±0.22 4.63±0.39a* 4.12±0.31b 3.76±0.33b 2.98±0.24b* 2.86±0.21b* 2.83±0.24b*
5’-ND (µmol of Pi liberated/min/mg 
protein)
3.54±0.31 8.44±0.65a* 7.23±0.56b 5.44±0.42b 4.01±0.29b* 4.32±0.38b* 4.26±0.41b*
Mammary tissue
γ-GT	(µmoles	of	p-nitroaniline	
liberated per min/mg of protein)
3.48±0.31 5.82±0.57 5.22±0.29b 4.58±0.43b* 3.71±0.54 3.73±0.42 3.74±0.62
LDH (µmoles of pyruvate liberated 
per minute/mg of protein)
2.57±0.25 4.35±0.39a* 3.99±0.62b 3.62±0.35b* 2.96±0.29b* 3.02±0.58b* 3.09±0.33b*
5’-ND (µmol of Pi liberated/min/mg 
protein)
2.62±0.36 3.94±0.18 3.64±0.40b 3.42±0.31b 2.83±0.30b* 2.94±0.22b* 2.87±0.42b*
Values	are	expressed	as	mean±SD;	n=6.	Group	I	-	Control,	Group	II	-	Mammary	carcinoma	induced,	Groups	III,	IV,	V,	VI,	and	VII	-	Mammary	carcinoma	induced	
and treated with AS at the dosage of 100, 150, 200, 250, and 300 mg/kg body weight/day, respectively. aWhen compared with Group I, bwhen compared with 
Group	II;	Statistical	significance:	*p<0.05.	γ-GT:	γ-glutamyl	transferase,	LDH:	Lactate	dehydrogenase,	5’-ND:	5’-Nucleotidase
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The lysosomal enzyme levels were reversion on drug-treated animals 
may be due to the stabilizing property of the drug on lysosomal 
membrane which could have been impacted by the flavonoids. It is 
well established that flavonoids have inhibiting property on lysosomal 
membranes. The drug may amend the lysosomal membrane in such 
a way that it is capable of blending with the plasma membrane and 
thereby preventing the discharge of acid hydrolases or by inhibiting the 
release of lysosomal enzyme [43]. The lysosomes can be acidified and 
activated by their proton pump and that can be inhibited by flavonoids 
might also be involved in experiential changes in lysosomal enzymes of 
drug-treated rats [44].
The analysis of marker enzymes can be used as an indication of 
neoplastic condition and therapy [45]. LDH is a tetrameric enzyme 
recognized as a marker with potential use in assessing the progression 
of the proliferating malignant cells. In the present study, the activities of 
LDH increase inbearing animals, possibly as a result of overproduction 
by cells [46]. LDH is a fairly sensitive marker for solid neoplasm [47]. 
Numerous reports reveal elevated LDH activity in various types of 
cancer [48]. This may be due to the higher glycolysis in the cancerous 
condition, which is the only energy-producing pathway for the 
uncontrolled proliferating malignant cells. The results of the current 
study show that 5’-ND activity was elevated in cancerous animals. 
Veena	et al. have reported that the increased activity of 5’-ND seems to 
have originated from the proliferating breast cells [49]. This elevation 
of the marker enzyme may be correlated with the progression of 
the malignancy. Walia et al. and Canbolat et al. have reported higher 
activities of 5’-ND in cancerous breast tissue of patients [50,51].
The	 γ-GT	 is	 a	 membrane-bound	 enzyme	 that	 is	 located	 on	 the	
external surface of cells that exhibit large secretory or detoxification 
activities [52]. The enzyme level is found to be raised in serum and 
liver in conditions such as cholestasis and bile duct necrosis and is also 
considered to be one of the best indicators of liver damage. A variety 
of substances including xenobiotics has been reported to become a 
substrate	of	 γ-GT	after	 their	 conjugation	 to	GSH,	occurring	mainly	 in	
the	 liver.	The	depletion	of	GSH	may	also	 induce	hepatic	γ-GT	activity	
through an increased synthesis of its mRNA [53]. In the present 
investigation,	 the	 γ-GT	 activity	was	 found	 to	 be	 increased	 in	 cancer-
bearing animals. This is well in accordance with the previous finding of 
Makpol et al., and Fentiman and Allen [54,55].
Several studies have proven the efficacy of flavonoids on tumor 
inhibition in various animal models [56]. The presence of flavonoids 
has been shown to impart inhibitory action against carcinogenesis. 
Phytoestrogens are phenolic non-steroidal plant compounds with 
estrogen-like biological activity. Most flavonoids are non-estrogenic or 
weakly estrogenic; however, the isoflavones such as genistein, other 
flavonoids such as apigenin and kaempferol, and the polyphenolic 
stilbenes such as resveratrol act through estrogen receptor-mediated 
mechanisms and also have antiestrogenic effects [57]. Flavonoids 
are polyphenolic compounds that occur ubiquitously in foods 
of plant origin. Flavonoids have a variety of biological effects in 
numerous mammalian cell systems, in vitro as well as in vivo. They 
have been shown to exert antimicrobial, antiviral, antiulcerogenic, 
cytotoxic, antineoplastic, mutagenic, anti-inflammatory, antioxidant, 
antihepatotoxic, antihypertensive, hypolipidemic, antiplatelet activities, 
as well as anticancer effect [58,59].
CONCLUSIONS
The results of the present study indicate that methanol extract of 
AS possesses strong anticancer effect. AS extract exerted a strong 
anticancer effect in a dose-dependent manner and its pronounced 
effect was observed at the dosage of 200 mg/kg body weight.
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